Bedfont named as Technology category finalist for 2019 National Family Business Awards

Medical device manufacturer, Bedfont Scientific Ltd., reaches the Family Business Awards finals for the Technology category. Created in order for family-owned businesses to be recognized and celebrated for their extraordinary contribution to the economy, the National Family Business Awards chose local med-tech firm, Bedfont, as a Technology category finalist for the 2019 awards.

Established in 1976, Bedfont specializes in the design and manufacture of innovative breath analysis medical devices. Its breath analyzers include carbon monoxide (CO) monitors such as the Smokerlyzer®, used for smoking cessation, and the ToxCO®, used by emergency services, to screen for CO poisoning. The NObreath® FeNO monitor provides accurate analysis of airway inflammation for the control of asthma, and the Gastrolyzer® range aids in the detection of gastrointestinal disorders and food intolerances. Quick and non-invasive, breath analysis is the new blood test.

Amalia Brightley-Gillott, Managing Director of Family Business Place, who hosts the awards, says:

We’re over the moon to welcome Bedfont Scientific Ltd. as Finalists at this year’s awards. They’re an exceptional example of how family businesses are leading the way, continuing to innovate and thriving in today’s competitive, economically uncertain world.”

Jason Smith, Managing Director, comments:

Becoming a 2nd generation family business has reinforced our family values and enabled us to create a strong sense of identity and culture for the business as the Bedfont Family. Strong family values can prove instrumental in stabilizing the structure and dynamics within the business resulting in high employee sense of belonging and satisfaction thus increasing productivity, loyalty and profitability. Breath analysis for medical applications is a very niche technology and we are thrilled to be recognized for our contribution to healthcare, by being chosen as a finalist in the Family Business Awards for the Technology category.”

The winners will be announced at Wembley Stadium on 13th July in what’s set to be a spectacular 10th anniversary celebration of the awards.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bedfont® Scientific Ltd. (2019, June 18). Bedfont named as Technology category finalist for 2019 National Family Business Awards. News-Medical. Retrieved on April 24, 2024 from https://www.news-medical.net/news/20190531/Bedfont-named-as-Technology-category-finalist-for-2019-National-Family-Business-Awards.aspx.

  • MLA

    Bedfont® Scientific Ltd. "Bedfont named as Technology category finalist for 2019 National Family Business Awards". News-Medical. 24 April 2024. <https://www.news-medical.net/news/20190531/Bedfont-named-as-Technology-category-finalist-for-2019-National-Family-Business-Awards.aspx>.

  • Chicago

    Bedfont® Scientific Ltd. "Bedfont named as Technology category finalist for 2019 National Family Business Awards". News-Medical. https://www.news-medical.net/news/20190531/Bedfont-named-as-Technology-category-finalist-for-2019-National-Family-Business-Awards.aspx. (accessed April 24, 2024).

  • Harvard

    Bedfont® Scientific Ltd. 2019. Bedfont named as Technology category finalist for 2019 National Family Business Awards. News-Medical, viewed 24 April 2024, https://www.news-medical.net/news/20190531/Bedfont-named-as-Technology-category-finalist-for-2019-National-Family-Business-Awards.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Prioritising Lung Health: How FeNO can help to tackle Lung Conditions, the UK's 3rd Largest Threat